Ophthalmic Drug GloStrips Recalled for Active Ingredient Impurities
FDA recalls GloStrips (Fluorescein Sodium) ophthalmic strips due to manufacturing defects in the active pharmaceutical ingredient. The API does not meet current USP purity standards for unspecified impurities.
- Product
- GLOSTRIPS — GLOSTRIPS (FLUORESCEIN SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide